Cardio Diagnostics Holdings (CDIO) Other Non Operating Income (2022 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Other Non Operating Income of -$3321.0 for Q1 2026, down 54.75% sequentially from -$2146.0 in Q4 2025, and up 26.27% YoY from -$2630.2 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Other Non Operating Income (2022 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Other Non Operating Income for 5 years, with the latest figure at -$3321.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 26.27% year-over-year to -$3321.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12906.0 (up 21.99% YoY) and the FY2025 annual result came in at -$14089.0, up 19.84% from the prior year.
- Other Non Operating Income retreated to -$3321.0 in Q1 2026 per CDIO's latest filing, from -$2146.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $670511.0 in Q1 2023 and troughed at -$883024.0 in Q4 2023.
- A 5-year average of -$84667.9 and a median of -$4504.0 in 2025 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 1266.11% in 2023, down 684.67% in 2023.
- Over 5 years, Other Non Operating Income stood at -$112534.0 in 2022, then sank by 684.67% to -$883024.0 in 2023, then soared by 99.67% to -$2906.0 in 2024, then gained by 26.15% to -$2146.0 in 2025, then slumped by 54.75% to -$3321.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$3321.0, -$2146.0, and -$2939.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.05 Mn | 460,682.10 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,321.00 |
| Mar 31, 2026 | -3,321.00 |
| Dec 31, 2025 | -2,146.00 |
| Sep 30, 2025 | -2,939.00 |
| Jun 30, 2025 | -4,500.00 |
| Mar 31, 2025 | -4,504.00 |
| Dec 31, 2024 | -2,906.00 |
| Sep 30, 2024 | -3,599.00 |
| Jun 30, 2024 | -5,535.00 |
| Mar 31, 2024 | -5,536.00 |
| Dec 31, 2023 | -883,024.00 |
| Sep 30, 2023 | -488,191.00 |
| Jun 30, 2023 | -364,295.00 |
| Mar 31, 2023 | 670,511.00 |
| Dec 31, 2022 | -112,534.00 |
| Mar 31, 2022 | -57,500.00 |